Dallah Healthcare to begin talks to buy remaining stake in associate firm

19/09/2022 Argaam

Logo of Dallah Healthcare Co.

Dallah Healthcare Co.’s board of directors decided, on Sept. 18, to start negotiations with shareholders selling their stake of 68.79%, or 34.395 million shares, in Dr Mohammad bin Rashed Al Faqih & Partners Co., according to a bourse filing.

 

Transaction Details

Subject of Transaction

Purchase of entire stake in associate firm Dr Mohammad Bin Rashed Al Faqih & Partners Co.

Status of Transaction

Negotiating with shareholders

Buyer

Dallah Healthcare

Seller

Remaining shareholders in Dr Mohammad Bin Rashed Al Faqih & Partners Co.

Target Ownership (Shares)

34.4 mln

Target Stake in Dr Mohammad Bin Rashed Al Faqih & Partners Co.

68.79%

Dallah Ownership in Associate

15.6 mln shares, or 31.21%
 
The relevant financial impact cannot be determined at present, the statement added.

 

Any related updates will be duly revealed.

 

For More Mergers and Acquisitions

Comments {{getCommentCount()}}

Be the first to comment

{{Comments.indexOf(comment)+1}}
{{comment.FollowersCount}}
{{comment.CommenterComments}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}} حساب موثّق

{{comment.ElapsedTime}}
loader Train
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.

Most Read